Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.
Kasseyet, S
Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura. [electronic resource] - Cancer Apr 1999 - 1740-9 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
0008-543X
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Asbestos--adverse effects
Cisplatin--administration & dosage
Combined Modality Therapy
Etoposide--administration & dosage
Female
Filgrastim
Fluorouracil--administration & dosage
Granulocyte Colony-Stimulating Factor--therapeutic use
Hematologic Diseases--chemically induced
Humans
Immunotherapy
Leucovorin--therapeutic use
Male
Mesothelioma--drug therapy
Middle Aged
Mitomycin--administration & dosage
Pleural Neoplasms--drug therapy
Prospective Studies
Recombinant Proteins
Remission Induction
Survival Analysis
Treatment Outcome
Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura. [electronic resource] - Cancer Apr 1999 - 1740-9 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
0008-543X
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Asbestos--adverse effects
Cisplatin--administration & dosage
Combined Modality Therapy
Etoposide--administration & dosage
Female
Filgrastim
Fluorouracil--administration & dosage
Granulocyte Colony-Stimulating Factor--therapeutic use
Hematologic Diseases--chemically induced
Humans
Immunotherapy
Leucovorin--therapeutic use
Male
Mesothelioma--drug therapy
Middle Aged
Mitomycin--administration & dosage
Pleural Neoplasms--drug therapy
Prospective Studies
Recombinant Proteins
Remission Induction
Survival Analysis
Treatment Outcome